Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 121-130 of 183 for lung disease

Edit search filters
  1. A Study of HFB200301 in Adult Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study to Assess Cardiopulmonary Measurements in Acute Respiratory Distress Syndrome (ARDS) Patients with Airway Pressure Release Ventilation

    Rochester, MN

  3. A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis

    Rochester, MN

  4. L-Carnitine for Fatigue in COPD

    Rochester, MN

  5. A Study of Inhaled Molgramostim in Cystic Fibrosis Subjects with Nontuberculous Mycobacterial (NTM) Infection

    Rochester, MN

  6. A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation

    Rochester, MN

  7. A Study to Assess the Effectiveness and Safety of PT009 Compared to PT005 for the Prevention of Moderate to Severe Episodes of Worsening COPD

    Rochester, MN

  8. A Study to Test New Technology and Health Coaching to Help People with COPD Become More Physically Active in Their Daily Lives

    Rochester, MN, Jacksonville, FL, Scottsdale/Phoenix, AZ

  9. EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures

    Rochester, MN

  10. Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis

    Rochester, MN

.

Mayo Clinic Footer